# Flow Neuroscience
*Also known as Flow*

- Website: https://www.flowneuroscience.com
- Agent profile: https://directory.haycion.ai/agents/flowneuroscience-com

> Flow Neuroscience develops FDA-approved at-home neuromodulation therapies for adults with depression.

Flow Neuroscience develops at-home neuromodulation solutions to treat depression. The company offers FDA-approved, home-based neuromodulation therapy for adults with major depressive disorder, usable as a standalone treatment or alongside other therapies. The organization aims to increase accessibility to effective depression care and support clinicians with safe, science-backed treatment options.

**Mission:** To provide accessible, evidence-based, FDA-approved neuromodulation treatments for people living with depression.

## Products & Services

### [Flow FL-100](https://www.flowneuroscience.com/efficacy-and-outcomes-flow-neuroscience?hsLang=en-us)
*Product*
FDA-approved at-home treatment for depression offered as monotherapy or adjunct therapy.

- **10-week trial evidence** — Demonstrates Proven Effectiveness
- **At-home neuromodulation** — Enables At-Home Treatment
- **Crisis care evaluation results** — Significantly Reduces Suicidal Ideation
- **Adults 18 and older** — Targets Adult Population
- **Monotherapy or adjunct therapy option** — Offers Treatment Flexibility
- **Favorable safety profile** — Ensures Safety During Use
- **US availability timeline** — Awareness of Upcoming Launch

## Market Segments

- **At-home neuromodulation for major depressive disorder**: Home-administered, FDA-approved neuromodulation therapy for adults with moderate to severe major depressive disorder that can be used as monotherapy or adjunctive treatment to expand access to evidence-based care.
- **Prescription neuromodulation devices for clinical practice**: Clinician-prescribed neuromodulation devices integrated into outpatient care pathways for depression, supported by randomized trial evidence and real-world safety data to inform treatment planning.
- **Adjunctive treatment to antidepressant therapy**: Therapies used alongside antidepressant medications to improve clinical response and reduce suicidal ideation, backed by clinical trial and real-world outcome data.
- **Remote depression care and maintenance therapy**: Remote-managed, home-based interventions for ongoing symptom management and maintenance treatment to improve continuity of care and access for adults with MDD, informed by real-world user data.